Daymark Wealth Partners LLC Trims Stock Position in GE HealthCare Technologies Inc. $GEHC

Daymark Wealth Partners LLC trimmed its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHCFree Report) by 4.7% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 5,044 shares of the company’s stock after selling 250 shares during the quarter. Daymark Wealth Partners LLC’s holdings in GE HealthCare Technologies were worth $374,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. N.E.W. Advisory Services LLC bought a new position in GE HealthCare Technologies in the 1st quarter worth approximately $25,000. Bogart Wealth LLC boosted its stake in GE HealthCare Technologies by 260.0% in the 1st quarter. Bogart Wealth LLC now owns 342 shares of the company’s stock worth $28,000 after purchasing an additional 247 shares during the period. Gladwyn Financial Advisors Inc. bought a new position in GE HealthCare Technologies in the 2nd quarter worth approximately $34,000. Olde Wealth Management LLC bought a new position in GE HealthCare Technologies in the 1st quarter worth approximately $35,000. Finally, Game Plan Financial Advisors LLC boosted its stake in GE HealthCare Technologies by 295.3% in the 2nd quarter. Game Plan Financial Advisors LLC now owns 502 shares of the company’s stock worth $37,000 after purchasing an additional 375 shares during the period. 82.06% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several research firms have weighed in on GEHC. BTIG Research set a $87.00 price target on GE HealthCare Technologies in a research note on Wednesday. Citigroup cut GE HealthCare Technologies from a “buy” rating to a “neutral” rating and decreased their price objective for the stock from $93.00 to $83.00 in a report on Tuesday, October 7th. Barclays assumed coverage on GE HealthCare Technologies in a report on Monday, October 13th. They set an “equal weight” rating and a $86.00 price objective on the stock. Wells Fargo & Company decreased their price objective on GE HealthCare Technologies from $89.00 to $87.00 and set an “overweight” rating on the stock in a report on Thursday. Finally, Morgan Stanley upped their price objective on GE HealthCare Technologies from $74.00 to $80.00 and gave the stock an “equal weight” rating in a report on Thursday. Six equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $86.10.

Read Our Latest Research Report on GE HealthCare Technologies

GE HealthCare Technologies Stock Performance

NASDAQ:GEHC opened at $74.95 on Friday. The stock’s fifty day moving average is $75.09 and its 200 day moving average is $72.99. GE HealthCare Technologies Inc. has a fifty-two week low of $57.65 and a fifty-two week high of $94.80. The firm has a market capitalization of $34.14 billion, a PE ratio of 15.49, a PEG ratio of 2.84 and a beta of 1.13. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.93 and a current ratio of 1.18.

GE HealthCare Technologies (NASDAQ:GEHCGet Free Report) last released its quarterly earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share for the quarter, beating the consensus estimate of $1.05 by $0.02. GE HealthCare Technologies had a return on equity of 22.52% and a net margin of 10.94%.The company had revenue of $5.14 billion for the quarter, compared to analyst estimates of $5.07 billion. During the same quarter in the prior year, the firm posted $1.14 EPS. GE HealthCare Technologies’s quarterly revenue was up 5.8% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. On average, sell-side analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 24th will be issued a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date is Friday, October 24th. GE HealthCare Technologies’s dividend payout ratio is presently 2.87%.

About GE HealthCare Technologies

(Free Report)

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.

Read More

Institutional Ownership by Quarter for GE HealthCare Technologies (NASDAQ:GEHC)

Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.